Mauna Kea Technologies SA (XPAR:ALMKT) Share Price

Company Profile

Business description
Mauna Kea Technologies SA is a medical device company that develops, manufactures and markets an imaging platform for visualizing tissue at the cellular level, in real time, during standard procedures, with the mission of eliminating uncertainties in diagnosis and treatment through direct visualization of tissue in vivo at the microscopic level. The company’s flagship product, Cellvizio, is the smallest microscope, designed for direct use during minimally invasive procedures. It operates in a single business segment: endomicroscopy. Its geographical presence includes EMEA (Europe, Middle East, Africa), USA and Canada, and Asia with the majority of the revenue deriving from USA and Canada.
Contact
9 rue d'Enghien
Paris75010
FRA
T: +33 148240345
https://www.maunakeatech.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
53

Recommended

Acquisition unlikely to improve prospects in the US and detracts from other opportunities.

Roy Van Keulen | 15 September 2025

Finding value in an expensive market.

Simonelle Mody | 15 September 2025

Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.

Joseph Taylor | 11 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,109.40	22.60	0.25%
CAC 40	7,825.24	1.72	0.02%
DAX 40	23,698.15	5.50	-0.02%
Dow JONES (US)	45,834.22	273.78	-0.59%
FTSE 100	9,283.29	14.29	-0.15%
HKSE	26,463.48	75.32	0.29%
NASDAQ	22,141.10	98.03	0.44%
Nikkei 225	44,768.12	395.62	0.89%
NZX 50 Index	13,194.77	33.13	-0.25%
S&P 500	6,584.29	3.18	-0.05%
S&P/ASX 200	8,842.30	20.90	0.24%
SSE Composite Index	3,879.28	8.69	0.22%